Cas no 1220035-47-1 (N-Butyl-N-methyl-4-piperidinamine dihydrochloride)

N-Butyl-N-methyl-4-piperidinamine dihydrochloride is a piperidine-based organic compound primarily utilized in pharmaceutical and chemical research. Its dihydrochloride salt form enhances stability and solubility, making it suitable for synthetic applications and biological studies. The compound features a tertiary amine structure, which can serve as a key intermediate in the synthesis of more complex molecules, including potential pharmacologically active agents. Its well-defined crystalline properties facilitate purification and characterization. The presence of both butyl and methyl substituents on the nitrogen atoms contributes to its lipophilicity, which may be advantageous in drug design for optimizing membrane permeability. This reagent is commonly employed in medicinal chemistry for scaffold modification and structure-activity relationship studies.
N-Butyl-N-methyl-4-piperidinamine dihydrochloride structure
1220035-47-1 structure
Product Name:N-Butyl-N-methyl-4-piperidinamine dihydrochloride
CAS No:1220035-47-1
MF:C10H24Cl2N2
MW:243.216960906982
CID:1079541
PubChem ID:53410849
Update Time:2025-06-10

N-Butyl-N-methyl-4-piperidinamine dihydrochloride Chemical and Physical Properties

Names and Identifiers

    • N-Butyl-N-methyl-4-piperidinamine dihydrochloride
    • AKOS015845518
    • 1220035-47-1
    • N-butyl-N-methylpiperidin-4-amine;dihydrochloride
    • N-butyl-N-methylpiperidin-4-aminedihydrochloride
    • N-butyl-N-methylpiperidin-4-amine dihydrochloride
    • MDL： MFCD13561565
    • Inchi： 1S/C10H22N2.2ClH/c1-3-4-9-12(2)10-5-7-11-8-6-10;;/h10-11H,3-9H2,1-2H3;2*1H
    • InChI Key： TZFJWPCNYHVPIM-UHFFFAOYSA-N
    • SMILES： Cl.Cl.N(C)(CCCC)C1CCNCC1

Computed Properties

  • Exact Mass: 242.1316542g/mol
  • Monoisotopic Mass: 242.1316542g/mol
  • Isotope Atom Count: 0
  • Hydrogen Bond Donor Count: 1
  • Hydrogen Bond Acceptor Count: 2
  • Heavy Atom Count: 14
  • Rotatable Bond Count: 4
  • Complexity: 108
  • Covalently-Bonded Unit Count: 3
  • Defined Atom Stereocenter Count: 0
  • Undefined Atom Stereocenter Count : 0
  • Defined Bond Stereocenter Count: 0
  • Undefined Bond Stereocenter Count: 0
  • Topological Polar Surface Area: 15.3?2

N-Butyl-N-methyl-4-piperidinamine dihydrochloride Security Information

N-Butyl-N-methyl-4-piperidinamine dihydrochloride Pricemore >>

Related Categories No. Product Name Cas No. Purity Specification Price update time Inquiry
Chemenu
CM307236-1g
N-Butyl-N-methylpiperidin-4-amine dihydrochloride
 1220035-47-1 95%
1g
 $167 2022-09-03
Chemenu
CM307236-5g
N-Butyl-N-methylpiperidin-4-amine dihydrochloride
 1220035-47-1 95%
5g
 $500 2022-09-03
TRC
N041665-125mg
N-Butyl-N-methyl-4-piperidinamine dihydrochloride
 1220035-47-1
125mg
 $ 230.00 2022-06-03
TRC
N041665-250mg
N-Butyl-N-methyl-4-piperidinamine dihydrochloride
 1220035-47-1
250mg
 $ 375.00 2022-06-03
SHANG HAI HAO HONG Biomedical Technology Co., Ltd.
1672524-5g
N-butyl-N-methylpiperidin-4-amine dihydrochloride
 1220035-47-1 98%
5g
 ￥6546.00 2024-08-09

N-Butyl-N-methyl-4-piperidinamine dihydrochloride Related Literature

Related Categories

Additional information on N-Butyl-N-methyl-4-piperidinamine dihydrochloride

N-Butyl-N-methyl-4-piperidinamine dihydrochloride (CAS No: 1220035-47-1) - A Comprehensive Overview

N-Butyl-N-methyl-4-piperidinamine dihydrochloride, identified by the CAS number 1220035-47-1, is a significant compound in the realm of pharmaceutical chemistry and drug development. This compound belongs to the piperidineamine class, which has garnered considerable attention due to its versatile biological activities and potential therapeutic applications. The dihydrochloride salt form enhances its solubility and stability, making it a valuable intermediate in synthetic chemistry and a promising candidate for further pharmacological exploration.

The molecular structure of N-Butyl-N-methyl-4-piperidinamine dihydrochloride consists of a piperidine ring substituted with a butyl group at the 1-position and a methyl group at the 4-position, linked to an amine group. This unique configuration imparts distinct chemical and pharmacological properties, enabling its utility in various biochemical pathways. The dihydrochloride formulation ensures better handling and reactivity, which is crucial for industrial-scale applications in drug synthesis.

In recent years, there has been a surge in research focused on developing novel therapeutic agents targeting neurological disorders. Piperidine derivatives, including N-Butyl-N-methyl-4-piperidinamine dihydrochloride, have shown promise in modulating neurotransmitter systems. Studies have indicated that this compound may interact with dopamine and serotonin receptors, potentially making it a viable candidate for treating conditions such as depression, anxiety, and Parkinson's disease. The ability to fine-tune the substituents on the piperidine ring allows for the development of analogs with enhanced selectivity and reduced side effects.

Moreover, the pharmaceutical industry has been exploring the use of N-Butyl-N-methyl-4-piperidinamine dihydrochloride as a building block for more complex molecules. Its structural features make it an excellent precursor for synthesizing intricate pharmacophores that can target specific disease mechanisms. Researchers have leveraged its reactivity to develop novel inhibitors and agonists, which are being tested in preclinical models for efficacy and safety.

One of the most compelling aspects of N-Butyl-N-methyl-4-piperidinamine dihydrochloride is its potential in oncology research. Preliminary studies suggest that this compound may exhibit anti-proliferative effects by interfering with key signaling pathways involved in cancer cell growth. By modulating enzymes such as tyrosine kinases, it could offer a new approach to combating certain types of cancer. Additionally, its ability to cross the blood-brain barrier enhances its appeal as a potential treatment for central nervous system tumors.

The synthesis of N-Butyl-N-methyl-4-piperidinamine dihydrochloride involves multi-step organic reactions that require precise control over reaction conditions. Advanced synthetic methodologies have been employed to optimize yield and purity, ensuring that the final product meets stringent pharmaceutical standards. Techniques such as catalytic hydrogenation and nucleophilic substitution are commonly used in its preparation, highlighting the compound's importance in synthetic chemistry.

In conclusion, N-Butyl-N-methyl-4-piperidinamine dihydrochloride (CAS No: 1220035-47-1) represents a significant advancement in pharmaceutical research. Its unique chemical properties and potential therapeutic applications make it a cornerstone in drug discovery efforts aimed at treating neurological disorders, cancer, and other debilitating conditions. As research continues to uncover new insights into its mechanisms of action, this compound is poised to play an increasingly vital role in the development of next-generation therapeutics.

1220035-47-1 (N-Butyl-N-methyl-4-piperidinamine dihydrochloride) Related Products

Recommended suppliers
Amadis Chemical Company Limited
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Reagent
Amadis Chemical Company Limited
Jinan Hanyu Chemical Co.,Ltd.
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Bulk
Jinan Hanyu Chemical Co.,Ltd.
Shanghai Jinhuan Chemical CO., LTD.
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Bulk
Shanghai Jinhuan Chemical CO., LTD.
PRIBOLAB PTE.LTD
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Reagent
PRIBOLAB PTE.LTD
SHOCHEM(SHANGHAI) CO.,lTD
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Bulk
SHOCHEM(SHANGHAI) CO.,lTD